Keyphrases
Real-life Data
100%
Improved Survival
100%
Dilated Cardiomyopathy
100%
Implantable Defibrillator
100%
Reduced Mortality
100%
Hypertension
33%
Mortality Benefit
33%
Chronic Kidney Disease
22%
Comorbidity
22%
Ischemic Heart Disease
22%
Significant Predictors
22%
Ventricular Arrhythmia
22%
Long-term Mortality
22%
Long-term Survival
22%
Patient-specific
11%
Activity Analysis
11%
Specific Information
11%
Beta-blockers
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Coding System
11%
Logistic Regression Analysis
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
11%
Increasing Age
11%
Heart Failure
11%
Logistic Regression Model
11%
Antihypertensive Medication
11%
Atrial Fibrillation
11%
Functional Status
11%
National Guidelines
11%
Ejection Fraction
11%
Real Patients
11%
Kaplan-Meier Curve
11%
Survival Prediction
11%
Mortality Prediction
11%
Symptom Status
11%
Local Health Authority
11%
Hospital Activity
11%
Medicine and Dentistry
Dilated Cardiomyopathy
100%
Implantable Automatic Defibrillator
100%
Logistic Regression Analysis
22%
Ischemic Heart Disease
22%
Chronic Kidney Disease
22%
Comorbidity
22%
Health Care Cost
11%
Drug Therapy
11%
Maturity Onset Diabetes of the Young
11%
Randomized Controlled Trial
11%
Antihypertensive Agent
11%
Beta Adrenergic Receptor Blocking Agent
11%
ACE Inhibitor
11%
Functional Status
11%
Atrial Fibrillation
11%
Ejection Fraction
11%
Kaplan Meier Method
11%
Congestive Heart Failure
11%
Ventricular Tachycardia
11%
Heart Ventricle Arrhythmia
11%
Long Term Survival
11%
Nursing and Health Professions
Implantable Cardioverter Defibrillator
100%
Congestive Cardiomyopathy
100%
Chronic Kidney Failure
22%
Ischemic Heart Disease
22%
Logistic Regression Analysis
22%
Comorbidity
22%
Drug Therapy
11%
Practice Guideline
11%
Non Insulin Dependent Diabetes Mellitus
11%
Antihypertensive Agent
11%
Atrial Fibrillation
11%
Functional Status
11%
Heart Ventricle Tachycardia
11%
Heart Ventricle Arrhythmia
11%
Long Term Survival
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Kaplan Meier Method
11%
Beta Adrenergic Receptor Blocking Agent
11%
Heart Ejection Fraction
11%
Congestive Heart Failure
11%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Cardiomyopathy
100%
Ischemic Heart Disease
25%
Chronic Kidney Failure
25%
Comorbidity
25%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Beta Adrenergic Receptor Blocking Agent
12%
Randomized Controlled Trial
12%
Atrial Fibrillation
12%
Antihypertensive Agent
12%
Functional Status
12%
Congestive Heart Failure
12%
Long Term Survival
12%
Heart Ventricle Tachycardia
12%
Heart Ventricle Arrhythmia
12%
Non Insulin Dependent Diabetes Mellitus
12%